China Resources Double-Crane Pharmaceutical Co Ltd

SSE:600062

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is China Resources Double-Crane Pharmaceutical Co Ltd's stock price target?

Price Target

24.79 CNY

According to Wall Street analysts, the average 1-year price target for China Resources Double-Crane Pharmaceutical Co Ltd is 24.79 CNY with a low forecast of 22.73 CNY and a high forecast of 27.41 CNY.

What is the Revenue forecast for China Resources Double-Crane Pharmaceutical Co Ltd?

Projected CAGR

5%

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 5%.

What is the Gross Profit forecast for China Resources Double-Crane Pharmaceutical Co Ltd?

Projected CAGR

-5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 2 years is -5%.

What is the Operating Income forecast for China Resources Double-Crane Pharmaceutical Co Ltd?

Projected CAGR

31%

Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 1 year is 31%.

What is the Pre-Tax Income forecast for China Resources Double-Crane Pharmaceutical Co Ltd?

Projected CAGR

8%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 8%.

What is the Net Income forecast for China Resources Double-Crane Pharmaceutical Co Ltd?

Projected CAGR

8%

Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 8%.